Actively Recruiting
The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions
Led by McGill University Health Centre/Research Institute of the McGill University Health Centre · Updated on 2026-05-01
100
Participants Needed
1
Research Sites
139 weeks
Total Duration
On this page
Sponsors
M
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead Sponsor
T
The Arthritis Society, Canada
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this prospective observational quality improvement study is to determine if a physician tool, MedSafer, combined with educational brochures for patients, can help to reduce the use of 'potentially inappropriate medications' (PIMs) in adults aged 60 and over with rheumatic conditions and polypharmacy (taking 5 or more regular medications). Researchers will follow participants during usual rheumatic disease care. They will compare the rate of PIM deprescribing (stopping medications or reducing the dose) before and after the introduction of the following interventions: * MedSafer reports provided to treating physicians * EMPOWER consumer brochures provided to participants Participants will complete 4 study visits over 18-20 months during which researchers will collect information on medication changes, serious adverse events (emergency visits or hospitalizations), and quality of life.
CONDITIONS
Official Title
The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 60 years or older
- Followed by a rheumatologist at MUHC for inflammatory arthritis, systemic autoimmune rheumatic disease, or another chronic musculoskeletal or rheumatic condition
- Currently taking 5 or more regular medications and at least 1 potentially inappropriate medication
- Expected to have ongoing rheumatology follow-up every 3 to 9 months
You will not qualify if you...
- Unable to provide informed consent
- Acute life-threatening illness or life expectancy less than 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Montreal General Hospital, McGill University Health Centre
Montreal, Quebec, Canada, H3G1A4
Actively Recruiting
Research Team
A
Arielle Mendel, MD MSc
CONTACT
J
Jeannette Bere, BSc, LPN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here